Company Name Clovis Oncology
Mailing Address 2525 28th Street Boulder, CO 80301
Company Description Clovis Oncology (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets.
Proceeds Purposes Proceeds purposes were not disclosed. Amount may include securities to be acquired upon exercise of option, warrants or other rights to acquire securities. Amount may also include convertible notes. SEC regulatory filing.